FDA Approves Third Over-the-Counter Opioid Overdose Nasal Spray

The FDA has approved a third over-the-counter opioid overdose nasal spray, expanding access to life-saving naloxone treatments. The approval gives consumers more options to combat the ongoing overdose crisis. Public health advocates have pushed for wider availability of the antidote.